Literature DB >> 14996008

Assessment of three chromogenic and one clotting assays for the measurement of synthetic pentasaccharide fondaparinux (Arixtra) anti-Xa activity.

F Depasse, G T Gerotziafas, J Busson, P Van Dreden, M M Samama.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14996008     DOI: 10.1111/j.1538-7933.2004.0584a.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  6 in total

Review 1.  [Anticoagulation].

Authors:  B Pötzsch
Journal:  Med Klin Intensivmed Notfmed       Date:  2013-05       Impact factor: 0.840

2.  Favorable coagulation profile with fondaparinux after hip surgery in elderly patients.

Authors:  Zuzana Kudrnová; Jan Kvasnička; Karel Kudrna; Jiří Mazoch; Ivana Malíková; Zuzana Zenáhlíková; Magda Sudrová; Radka Brzežková
Journal:  Int J Hematol       Date:  2009-10-17       Impact factor: 2.490

3.  Role of factor xa inhibitors in cancer-associated thrombosis: any new data?

Authors:  Ali Zalpour; Michael H Kroll; Vahid Afshar-Kharghan; Syed Wamique Yusuf; Carmen Escalante
Journal:  Adv Hematol       Date:  2011-10-15

Review 4.  New anticoagulants for the prevention and treatment of venous thromboembolism.

Authors:  Simon J McRae; Jeffrey S Ginsberg
Journal:  Vasc Health Risk Manag       Date:  2005

Review 5.  Guidance for the practical management of the heparin anticoagulants in the treatment of venous thromboembolism.

Authors:  Maureen A Smythe; Jennifer Priziola; Paul P Dobesh; Diane Wirth; Adam Cuker; Ann K Wittkowsky
Journal:  J Thromb Thrombolysis       Date:  2016-01       Impact factor: 2.300

6.  Impaired platelet-dependent thrombin generation associated with thrombocytopenia is improved by prothrombin complex concentrates in vitro.

Authors:  Pratima Chowdary; Colleen Hamid; David Slatter; Richard Morris; Jonathan H Foley; Keith Gomez; Edgar Brodkin; Thomas A Fox; Alex Gatt; John H McVey
Journal:  Res Pract Thromb Haemost       Date:  2020-02-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.